Log in
Enquire now
NanoCor Therapeutics

NanoCor Therapeutics

A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/nanocor-therapeutics
B2X
B2B
B2B
CEO
Sheila Mikhail
Sheila Mikhail
CIK Number
1,352,203
Company Operating Status
Closed
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
Date Incorporated
November 16, 2006
DUNS Number
6064300
Founded Date
January 1, 2005
Founder
Sheila Mikhail
Sheila Mikhail
Full Address
870 Martin Luther King Jr Blvd Chapel Hill​, NC, 27514-2600 United States
Industry
Genetics
Genetics
Technology
Technology
Therapeutics
Therapeutics
Biology
Biology
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Biotechnology
Biotechnology
Investors
Medtronic
Medtronic
Latest Funding Round Date
June 2009
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/nanocor-therapeutics-inc./about
Location
Chapel Hill, North Carolina
Chapel Hill, North Carolina
North Carolina
North Carolina
Number of Employees (Ranges)
1 – 10
Spun Out From
Asklepios Biopharmaceutical
Asklepios Biopharmaceutical
Total Funding Amount (USD)
17,550,000
Official Website
nanocortherapeutics.com
nanocorthx.com
Wellfound ID
nanocor-therapeutics
Wikidata ID
Q64142096

Find more companies like NanoCor Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.